3,929
Views
55
CrossRef citations to date
0
Altmetric
Review articles

Zinc, aging, and immunosenescence: an overview

Article: 25592 | Received 29 Jul 2014, Accepted 09 Dec 2014, Published online: 05 Feb 2015

References

  • Chasapis CT, Loutsidou AC, Spilipoulou CA, Stefanidou ME. Zinc and human health: an update. Arch Toxicol. 2012; 86(4): 521–34.
  • Mocchegiani E, Romeo J, Malavolta M, Costarelli L, Giacconi R, Díaz LE, etal. Zinc: dietary intake and impact of supplementation on immune function in elderly. Age (Dordr). 2013; 35(3): 839–60.
  • Alonso P, De la Fuente M. Role of the immune system in aging and longevity. Curr Aging Sci. 2011; 4(2): 78–100.
  • Lang PO, Govind S, Michel JP, Aspinall R, Mitchell WA. Immunosenescence: implications for vaccination programs in adults. Maturitas. 2011; 68(4): 322–30.
  • Oliveira BF, Nogueira JA, Chaves MM. The role of oxidative stress in the aging process. ScientificWorldJournal. 2010; 10: 1121–8. 10.1100/tsw.2010.94.
  • Candore G, Caruso C, Colonna G. Inflammation, genetic background and longevity. Biogerontology. 2010; 11(5): 656–73.
  • Mocchegiani E, Malavolta M, Costarelli L, Giacconi R, Cipriano C, Piacenza F, etal. Zinc, metallothioneins and immunosenescence. Proc Nutr Soc. 2010; 69(3): 290–9.
  • Haase H, Rink L. The immune system and the impact of zinc during aging. Immun Ageing. 2009; 6: 9–26. 10.1186/1742-4933-6-9.
  • Mocchegiani E, Costarelli L, Giacconi R, Piacenza E, Basso A, Malavolta M. Zinc, metallothioneins and immunosenescence: effect of zinc supply as nutrigenic approach. Biogerontology. 2011; 12(5): 455–65.
  • Haase H, Rink L. Zinc signals and immune function. Biofactors. 2014; 40: 27–40. 10.1002/biof.1114.
  • Ryu MS, Langkamp B, Chang SM, Shankai MN, Cousins RJ. Genomic analysis, cytokine expression and microRNA profiling reveal biomarkers of human dietary zinc depletion and homeostasis. Proc Natl Acad Sci USA. 2001; 108(2): 20970–5.
  • Mochegiani E, Costarelli L, Giacconi R, Piacenza F, Basso A, Malavolta M. Micronutrient (Zn, Cu, Fe)–gene interactions in ageing an inflammatory age-related diseases: implications for treatment. Ageing Res Rev. 2012; 11(2): 297–319.
  • Prasad AS. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol. 2008; 43(5): 370–7.
  • Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med. 2008; 14(5–6): 353–7.
  • Tuerk MJ, Fazel N. Zinc deficiency. Curr Opin Gastroenterol. 2009; 25(2): 136–43.
  • Prasad AS. Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr. 2013; 4(2): 176–90.
  • Yakoob MY, Theodoratou E, Jabeen A, Imdab A, Eisele TP, Ferguson J, etal. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health. 2011; 11(Suppl 3): 3–23.
  • Prasad AS. Impact of the discovery of human zinc deficiency on health. J Am Coll Nutr. 2009; 28(3): 257–65.
  • Hui J, Tang NL. Wilson's disease: a review of treatment options with a focus on zinc therapy. Orphan Drugs. 2012; 2: 35–45.
  • Szewczyk B. Zinc homeostasis and neurodegenerative disorders. Front Ageing Neurosci. 2013; 5: 33. 10.3389/fnagi2013.00033.
  • Plum LM, Rink L, Haase H. The essential toxin: impact of zinc on human health. Int J Environ Res Public Health. 2010; 7(4): 1342–65.
  • Brewer GJ, Kanzer SH, Zimmerman EA, Molho ES, Celmins DF, Heckman SM, etal. Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease. Am J Alzheimers Dis Other Demen. 2010; 25(7): 572–5.
  • Brewer GJ, Kaur S. Zinc deficiency and zinc therapy efficacy with reduction of serum free copper in Alzheimer's disease. Int J Alzheimers Dis. 2013; 2013: 586365.
  • Ranjbar E, Kasaei MS, Mohammad-Shirazi M, Nasrollahzadeh J, Rashidkhani B, Shams J, etal. Effects of zinc supplementation in patients with major depression: a randomized clinical trial. Iran J Psychiatry. 2013; 8(2): 73–9.
  • Li P, Xu J, Shi Y, Ye Y, Chen K, Yang J, etal. Association between zinc intake and risk of digestive tract cancers: a systematic review and meta-analysis. Clin Nutr. 2014; 33: 415–20. 10.1016/j.clnu.2013.10.001.
  • Golabek T, Darewicz B, Borawska M, Socha K, Markiewicz R, Kudelski J. Copper, zinc, and Cu/Zn ratio in transitional cell carcinoma of the bladder. Urol Int. 2012; 89(3): 342–7.
  • Mao S, Huang S. Zinc and copper levels in bladder cancer: a systematic review and meta-analysis. J Trace Elem Res. 2013; 153(1–3): 5–10.
  • Rasmussen HM, Johnson EJ. Nutrients for the aging eye. Clin Interv Aging. 2013; 8: 741–8.
  • Visharanathan R, Chung M, Johnson EJ. A systematic review on zinc for the prevention and treatment of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013; 54(6): 3985–98.
  • Aliani M, Udenigure CC, Girgih AT, Povenall TL, Bugera JL, Eskin MN. Zinc deficiency and taste perception in the elderly. Crit Rev Food Sci Nutr. 2013; 53(3): 245–50.
  • Bao B, Prasad AS, Beck FW, Snell D, Suneya A, Sarkar FH, etal. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cells disease patients. Transl Res. 2008; 152(2): 67–80.
  • Arnold CR, Wolf J, Brunner S, Heindler D, Gurbeck B. Gain and loss of T cells subsets in old-age-related reshaping of the T cell repertoire. J Clin Immunol. 2011; 31(2): 137–46.
  • Aw D, Palmer DB. It's not all equal: a multiphasic theory of thymic involution. Biogerontology. 2012; 13(1): 77–81.
  • Henson SM, Akbar AN. Memory T cell homeostasis and senescence during aging. Adv Exp Med Biol. 2010; 684: 187–97.
  • Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, Löfgren S, etal. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci. 2005; 60: 556–65.
  • Wikby A, Nilsson BD, Forsey R, Thompson J. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev. 2006; 127: 695–704.
  • Romero AJ, Amores L, Fernández E. Immunosenescence and frailty: a current glance. Med Int Mex. 2013; 29(6): 605–11.
  • Pawelec G. Hallmarks of human “immunosenescence”: adaptation or dysregulation?. Immun Ageing. 2012; 9(1): 15.
  • Le Saux S, Weyand CM, Goranzy JJ. Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci. 2012; 1247: 69–82.
  • Sada-Ovalle I, Gorocica P, Lascurain R, Zenteno E. Immunological aspects of aging. Rev Inst Nac Enf Resp Mex. 2004; 17: 293–300.
  • Gruver A, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007; 211: 144–56.
  • Pawelec G, McElhaney JE, Aiello AE, Derhovanessian E. The impact of CMV infection on survival of older humans. Curr Opin Immunol. 2012; 24(4): 507–11.
  • Wills M, Akbar A, Beswick M, Bosch JA, Caruso C, Colonna-Romano G, etal. Report from the second cytomegalovirus and immunosenescence workshop. Immun Ageing. 2011; 8: 10. 10.1186/1742-4933-8-10.
  • Dock JN, Effros RB. Role of CD8 T cell replicative senescence in human aging and HIV-mediated immunosenescence. Aging Dis. 2011; 2(5): 382–97.
  • Lindstrom TM, Robinson WH. Rheumatoid arthritis: a role for immunosenescence?. J Am Geriatr Soc. 2010; 58: 1565–75.
  • Candore G, Caruso C, Jirillo E, Magrone T, Vasto S. Low grade inflammation as a common pathogenic denominator in age-related diseases: novel drug targets for anti-aging strategies and successful ageing achievement. Curr Pharm Des. 2010; 16(6): 584–96.
  • Hubbard RE, O'Mahoney MS, Calver BL, Woodhouse KW. Plasma esterases and inflammation in ageing and frailty. Eur J Clin Pharmacol. 2008; 64: 895–900.
  • Cannizo ES, Clement CC, Sahu R, Follo C, Santambrogio L. Oxidative stress, inflam-aging and immunosenescence. J Proteomics. 2011; 74(11): 2313–23.
  • De la Fuente M, Miquel J. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflam-aging. Curr Pharm Des. 2009; 15(26): 3003–26.
  • De la Fuente M. Role of the immune system in aging. Inmunology. 2008; 27(4): 176–91.
  • Salvioli S, Monti D, Lanzarini C, Conte M, Pirazzini C, Bacalini MG, etal. Immune system, cell senescence, aging and longevity: inflam-aging reappraised. Curr Pharm Des. 2013; 19: 1675–9.
  • Franceschi C, Capri M, Monti D, Giunta S, Oliveiri F, Serrini F, etal. Inflammaging and anti-inflammaging: a systematic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007; 128: 92–105.
  • Lang PO, Mitchell WA, Lapenna A, Pitts D, Aspinall R. Immunological pathogenesis of main age-related diseases and frailty: role of immunosenescence. Eur Geriatr Med. 2010; 1: 112–21.
  • Nishida K. New knowledge from past decade: role of zinc in immune system. Nihon Eiseigaku Zasshi. 2013; 68(3): 145–52.
  • Wong CP, Ho E. Zinc and its role in age-related inflammation and immune dysfunction. Mol Nutr Food Res. 2012; 56(1): 77–87.
  • Prasad AS. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care. 2009; 12(6): 646–52.
  • Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. 2006; 20(1): 3–18.
  • Muñoz C, Vázquez C, De Cos AI, Gómez C, Reuss JM. Alimentación en el anciano sano. Manual de recomendaciones nutricionales en pacientes geriátricos. 2004; Madrid: Novartis Consumer Health, SA. 99–106.
  • Trinch C, Morley JE, Thomas DR. Immunity and nutrition. Geriatric nutrition. Boca Ratón. 2007; FL: CRC Press. 69–102.
  • Doets EL, Cavelaars AE, Dhonukshe-Rutten RA, van't Veer P, de Groot LC. Explaining the variability in recommended intakes of folate, vitamin B12, iron and zinc for adults and elderly people. Public Health Nutr. 2012; 15(5): 906–15.
  • Joshi S, Morley JE, Pathy J, Sinclair AJ, Morley JE. Vitamins and minerals in the elderly. Principles and practice of geriatric medicine. 2006; 4th ed, Chichester, West Susex: Wiley. 329–46.
  • Madej D, Borowska K, Bylinowska J, Szybalska A, Pietruszka B. Dietary intakes of iron and zinc assessed in a select group of the elderly: are they adequate?. Rocz Panstw Zakl Hig. 2013; 64(2): 97–104.
  • Vasto S, Mocchegiani E, Malavolta M, Cuppari I, Listi F, Nuzzo D, etal. Zinc and inflammatory/immune response in ageing. Ann N Y Acad Sci. 2007; 1100: 111–22.
  • Roohani N, Huvell R, Kelishadi R, Schulin R. Zinc and its importance for human health: an integrative review. J Res Med Sci. 2013; 18(2): 144–57.
  • Kosaka K, Yamashita S, Ando C, Endo Y, Taniguchi K, Kikunaga S. Relationships among body mass index, activities of daily living and zinc nutritional status in disabled elderly patients in nursing facilities. J Nutr Sci Vitaminol (Tokyo). 2013; 59(5): 420–30.
  • Giacconi R, Malavolta M, Costarelli L, Busco F, Galeazzi R, Bernardini G, etal. Comparison of intracellular zinc signals in nonadherent lymphocytes from young and elderly donors: role of zinc transporters (Zip family) and proinflammatory cytokines. J Nutr Biochem. 2012; 23(10): 1256–63.
  • Mocchegiani E, Costarelli L, Basso A, Giacconi R, Piacenza F, Malavolta M. Metallothioneins, ageing and cellular senescence: a future therapeutic target. Curr Pharm Des. 2013; 19(9): 1753–64.
  • Mocchegiani E, Giacconi R, Cipriano C, Malavolta M. NK and NKT cells in aging and longevity: role of zinc and metallothioneins. J Clin Immunol. 2009; 29(4): 416–25.
  • Prasad AS. Zinc: mechanisms of host defense. J Nutr. 2007; 137(5): 1345–9.
  • Mocchegiani E, Malavolta M, Costarelli L, Giacconi R, Piacenza F, Lattanzio F, etal. Is there a possible single mediator in modulating neuroendocrine–thymus interaction in aging?. Curr Aging Sci. 2013; 6(1): 99–107.
  • Hirano T, Murakami M, Fukada T, Yamasaki S, Susuki T. Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule. Adv Immunol. 2008; 97: 149–76.
  • Yu M, Lee WW, Tomar D, Pryschep S, Czesnikiewicz M, Lamar DL, etal. Regulation of T cell receptor signaling by activation-induced zinc influx. J Exp Med. 2011; 208(4): 775–85.
  • Fukada T, Yamasaki S, Nishida K, Murakami M, Hirano T. Zinc and signaling in health and diseases: zinc signaling. J Biol Inorg Chem. 2011; 16(7): 1123–34.
  • Maret W. Molecular aspects of human cellular zinc homeostasis: redox control of zinc potentials and zinc signals. Biometals. 2009; 22(1): 149–57.
  • Haase H, Rink L. Functional significance of zinc-related signaling pathways in immune cells. Annu Rev Nutr. 2009; 29: 133–52.
  • Morgan CI, Ledford JR, Zhou P, Page K. Zinc supplementation alters airway inflammation and airway hyperresponsiveness to a common allergen. J Inflamm (Lond). 2011; 8: 36. 10.1186/1476-9255-8-36.
  • Kriskova S, Ryvolona M, Hrabeta J, Adam V, Stiborova M, Eckschlager T, etal. Metallothioneins and zinc in cancer diagnosis and therapy. Drug Metab Rev. 2012; 44(4): 287–301.
  • Prasad AS, Bao B, Beck FW, Sarkar FH. Zinc-suppressed inflammatory cytokines by induction of A-20-mediated inhibition of nuclear factor-κB. Nutrition. 2011; 27(7–8): 816–23.
  • Napetschnig J, Wu H. Molecular basis of NF-κB signaling. Annu Rev Biophys. 2013; 42: 443–68.
  • Liu MJ, Bao B, Gálvez-Peralta M, Pyle CJ, Rudawsky AC, Pavlowicz RE, etal. ZIP 8 regulates host defense through zinc-mediated inhibition of NF-κB. Cell Rep. 2013; 3(2): 386–400.
  • Balistreri C, Candore G, Accardi G, Colonna-Romano G, Lio D. NF-κB pathway activators as potential ageing biomarkers: targets for new therapeutic strategies. Immun Ageing. 2013; 10: 24–40.
  • Sharma S, Rais A, Sandhu R, Nel W, Ebadi M. Clinical significance of metallothioneins in cell therapy and nanomedicine. Int J Nanomed. 2013; 8: 1477–88.
  • Knoell DL, Liu MJ. Impact of zinc metabolism on innate immune function in the setting of sepsis. Int Z Vitam Ernahrungsforsch Beih. 2010; 80(4–5): 271–7.
  • Haase H, Rink L. Signal transduction in monocytes: the role of zinc ions. Biometals. 2007; 20(3–4): 579–85.
  • Rink L, Haase H. Zinc homeostasis and immunity. Trends Immunol. 2007; 28(1): 1–4.
  • Tsou TC, Chao HR, Yeh SC, Tsai FY, Lin HJ. Zinc induces chemokine and inflammatory cytokine release from human promonocytes. J Hazard Mater. 2011; 196: 335–41.
  • Ibs RH, Rink L. Zinc-altered immune function. J Nutr. 2003; 133(5 Suppl 1): 1452–65.
  • Gruber K, Maywald M, Rosenbranz E, Haase H, Plumakers B, Rink L. Zinc deficiency adversely influences interleukin-4 and interleukin-6 signaling. J Biol Regul Homeost Agents. 2013; 27(3): 661–71.
  • Suwendi E, Iwaya H, Lee JS, Hara H, Ishizuka S. Zinc deficiency induces dysregulation of cytokine productions in an experimental colitis of rats. Biomed Res. 2012; 33(6): 329–36.
  • Foster M, Samman S. Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients. 2012; 4(7): 676–94.
  • Bao S, Liu MJ, Lee B, Besecker B, Lai JP, Guttridge DC, etal. Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NK-κB. Am J Physiol Lung Cell Mol Physiol. 2010; 298(6): L744–54.
  • Wong CP, Magnusson KR, Ho E. Increased inflammatory response in aged mice is associated with age-related zinc deficiency and zinc transporter dysregulation. J Nutr Biochem. 2013; 24(1): 353–9.
  • Prasad AS, Beck FWJ, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, etal. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative estrés. Am J Clin Nutr. 2007; 85: 837–44.
  • Meydani SN, Barnett JB, Dollal GE, Fine BC, Jacques PF, Leka LS, etal. Serum zinc and pneumonia in nursing home elderly. Am J ClinNutr. 2007; 86: 1167–73.
  • Bao B, Prasad AS, Beck F, Fitzgerald JT, Snell D, Bao CW, etal. Zinc decreases C-reactive protein, lipid peroxidation and inflammatory cytokines in elderly subjects. A potential implication of zinc as an atheroprotective agent. Am J Clin Nutr. 2010; 91: 1634–41.
  • Guo CH, Wang CL. Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients. Int J Med Sci. 2013; 10(1): 79–89.
  • Hamza SA, Mousa SM, Taha SE, Adel LA, Samaha HE, Hussein DA. Immune response of 23-valent pneumococcal polysacharide vaccinated elderly and its relation to frailty indices, nutritional status and serum zinc levels. Geriatr Gerontol Int. 2012; 12(2): 223–9.
  • Yalçın SS, Engür-Karasimav D, Alehan D, Yurdakök K, Ozkutlu S, Coşkun T. Zinc supplementation and TNF-α levels in vaccinated cardiac patients. J Trace Elem Med Biol. 2011; 25(2): 85–90.
  • Afsharian M, Vaziri S, Janbakhsh AR, Sayad B, Mansouri F, Nourbakhsh J, etal. The effect of zinc sulfate on immunologic response to recombinant hepatitis B vaccine in elderly: zinc sulfate and immunologic response to recombinant hepatitis B vaccine. Hepat Mon. 2011; 11(1): 32–5.
  • Das JK, Kumar R, Salam RA, Bhutta ZA. Systematic review of zinc fortification trials. Ann Nutr Metab. 2013; 62(Suppl 1): 44–56.
  • Penny ME. Zinc supplementation in public health. Ann Nutr Metab. 2013; 62(Suppl 1): 31–42.
  • Pae M, Meydani SN, Wu D. The role of nutrition in enhancing immunity in aging. Aging Dis. 2012; 3(1): 91–129.
  • Sheqwara J, Alkhatib Y. Sideroblastic anemia secondary to zinc toxicity. Blood. 2013; 122(3): 311.
  • Kuyumcu ME, Yesil Y, Ozturk ZA, Cankurtaran M, Ulger Z, Halil M, etal. An alternative way for the evaluation of zinc status in the elderly; nail zinc levels and relationship with Alzheimer's disease. Eur Rev Med Pharmacol Sci. 2013; 17(11): 1467–71.
  • Mocchegiani E, Basso A, Giacconi R, Piacenza F, Costarelli L, Pierpaoli S, etal. Diet (zinc)–gene interaction related to inflammatory/immune response in ageing: possible link with frailty syndrome?. Biogerontology. 2010; 11(5): 589–95.